CME Group Inc. (NASDAQ:CME) Receives Average Rating of "Hold" from Analysts

CME Group Inc. (NASDAQ:CME - Get Free Report) has earned an average rating of "Hold" from the sixteen ratings firms that are currently covering the stock, Marketbeat Ratings reports. Three analysts have rated the stock with a sell rating, eight have issued a hold rating and five have issued a buy rating on the company. The average 1-year target price among brokerages that have issued ratings on the stock in the last year is $259.87.

Several equities research analysts have recently weighed in on CME shares. Wall Street Zen upgraded shares of CME Group from a "sell" rating to a "hold" rating in a research note on Saturday. UBS Group increased their target price on shares of CME Group from $290.00 to $305.00 and gave the stock a "buy" rating in a research note on Friday, April 25th. Keefe, Bruyette & Woods increased their target price on shares of CME Group from $265.00 to $273.00 and gave the stock a "market perform" rating in a research note on Thursday, April 24th. Royal Bank Of Canada reiterated a "sector perform" rating and set a $269.00 target price on shares of CME Group in a research note on Thursday, April 3rd. Finally, Raymond James Financial raised CME Group from a "market perform" rating to an "outperform" rating and set a $287.00 price objective on the stock in a report on Monday, March 10th.

Insider Buying and Selling at CME Group

In other news, Director Charles P. Carey sold 500 shares of the company's stock in a transaction on Tuesday, June 10th. The stock was sold at an average price of $265.35, for a total transaction of $132,675.00. Following the completion of the sale, the director directly owned 4,900 shares in the company, valued at $1,300,215. This represents a 9.26% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, Director Daniel G. Kaye sold 500 shares of the company's stock in a transaction on Thursday, May 22nd. The stock was sold at an average price of $282.42, for a total transaction of $141,210.00. Following the sale, the director directly owned 3,668 shares of the company's stock, valued at approximately $1,035,916.56. This trade represents a 12.00% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 13,400 shares of company stock worth $3,680,610. 0.30% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On CME Group

A number of institutional investors have recently modified their holdings of CME. Wayfinding Financial LLC acquired a new stake in CME Group during the first quarter worth about $25,000. Cornerstone Planning Group LLC raised its stake in CME Group by 122.2% during the first quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider's stock worth $26,000 after acquiring an additional 55 shares during the period. Golden State Wealth Management LLC raised its stake in CME Group by 612.5% during the first quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider's stock worth $30,000 after acquiring an additional 98 shares during the period. Ransom Advisory Ltd acquired a new stake in shares of CME Group in the first quarter valued at approximately $31,000. Finally, Alpine Bank Wealth Management acquired a new stake in shares of CME Group in the first quarter valued at approximately $32,000. Institutional investors and hedge funds own 87.75% of the company's stock.

CME Group Stock Performance

Shares of CME stock opened at $282.55 on Tuesday. The stock's 50-day moving average is $276.69 and its two-hundred day moving average is $258.49. The firm has a market cap of $101.82 billion, a price-to-earnings ratio of 28.43, a PEG ratio of 3.75 and a beta of 0.44. CME Group has a 1 year low of $193.17 and a 1 year high of $290.79. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02.

CME Group (NASDAQ:CME - Get Free Report) last issued its quarterly earnings data on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.61 by $0.19. The company had revenue of $1.64 billion for the quarter, compared to analyst estimates of $1.56 billion. CME Group had a return on equity of 14.03% and a net margin of 57.71%. The business's quarterly revenue was up 10.4% compared to the same quarter last year. During the same quarter last year, the company posted $2.50 earnings per share. Analysts predict that CME Group will post 10.49 earnings per share for the current year.

CME Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, June 25th. Stockholders of record on Monday, June 9th were issued a dividend of $1.25 per share. The ex-dividend date was Monday, June 9th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.77%. CME Group's payout ratio is 50.30%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.